Metaplastic breast carcinoma: A case report and systematic review of the literature

Pathology International

Volumn 61, Issue 10, 2011, Pages 582-588

  Toumi, Zaher ^a   Bullen, Caroline ^a   Tang, Albert C S ^c   Dalal, Neha ^b   Ellenbogen, Simon ^a  

^a Department of General Surgery ^*  (United Kingdom)

^b TAMESIDE GENERAL HOSPITAL   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Breast cancer; Case report; Matrix producing breast cancer; Metaplastic breast cancer; Systematic review

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; CALCIUM CARBONATE; CALCIUM CARBONATE PLUS VITAMIN D3; CALPONIN; COLECALCIFEROL; CYTOKERATIN 14; CYTOKERATIN 5; CYTOKERATIN 6; CYTOKERATIN 8; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPITHELIAL MEMBRANE ANTIGEN; ESTROGEN RECEPTOR; LETROZOLE; MYOSIN; PROGESTERONE RECEPTOR; PROTEIN P63; PROTEIN S 100; TAMOXIFEN; UNCLASSIFIED DRUG;

AGED; ARTICLE; ASPIRATION; ASPIRATION BIOPSY; ASPIRATION CYTOLOGY; BREAST CARCINOMA; BREAST DISCHARGE; BREAST EPITHELIUM; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CASE REPORT; DISEASE FREE SURVIVAL; DISTANT METASTASIS; ECHOGRAPHY; ETHNICITY; FAMILY HISTORY; FEMALE; FOLLOW UP; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAMMOGRAPHY; MASTECTOMY; MEDICAL HISTORY; METAPLASTIC BREAST CARCINOMA; MICROARRAY ANALYSIS; MITOSIS; MULTIMODALITY CANCER THERAPY; MYOEPITHELIUM CELL; NIPPLE; OSTEOPOROSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PHENOTYPE; PLEOMORPHIC ADENOMA; PRIORITY JOURNAL; PROGNOSIS; PUNCH BIOPSY; SENTINEL LYMPH NODE BIOPSY; SEROMA; SPINDLE CELL; SQUAMOUS CELL METAPLASIA; SYSTEMATIC REVIEW; TRIPLE NEGATIVE BREAST CANCER; TUMOR CELL;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; FEMALE; HUMANS; METAPLASIA; MIXED TUMOR, MALIGNANT; NITRILES; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TRIAZOLES; TUMOR MARKERS, BIOLOGICAL;

EID: 80053328977     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2011.02698.x     Document Type: Article

References (27)

1. Hirose T, Honda J, Bando Y etal. A case of Matrix-producing Carcinoma of the breast. World J Surg Oncol 2008; 6: 60.
2. Johnson TL, Kinni SR. Metaplastic breast carcinoma: A cytohistologic and clinical study of 10 cases. Diagn Cytopathol 1999; 14: 226-32.
3. Chao TC, Wang CS, Chen SC etal. Metaplastic carcinomas of the breast. J Surg Oncol 1999; 71: 220-5.
4. Rayson D, Adjei AA, Suman VJ etal. Metaplastic breast cancer: Prognosis and response to systemic therapy. Ann Oncol 1999; 10: 413-9.
5. Tse GM, Tan PH, Putti TC etal. Metaplastic carcinoma of the breast: A clinicopathological review. J Clin Pathol 2006; 59: 1079-83.
6. Davis WG, Hennessy B, Babiera G etal. Metaplastic sarcomatoid carcinomas of the breast with absent or minimal overt invasive carcinomatous component. Am J Surg Pathol 2006; 30: 1052-3.
7. AI Sayed AD, EI Weshi AN, Tulbah AM etal. Metaplastic carcinoma of the breast clinical presentation, treatment results and prognostic factors. Acta Oncol 2006; 45: 188-95.
8. Hennessy BT, Giordano S, Broglio K etal. Biphasic Metaplastic Sarcomatoid carcinoma of the breast. Ann Oncol 2006; 17: 605-13.
9. Luini A, Aguilar M, Gatti G etal. Metaplastic carcinoma of the breast, an unsual disease with worse prognosis: The experience of the European Institute of Oncology and review of the literature. Breast Cancer Res Treat 2007; 101: 349-53.
10. Lim KH, Oh DY, Chie EK etal. Metaplastic breast carcinoma: clincopathologic features and prognostic value of triple negativity. Jap J Clin Oncol 2010; 40: 112-8.
11. Dave G, Cosmatos H, Do T etal. Metaplastic carcinoma of the breast: A retrospective review. Int J Radiat Oncol 2006; 64: 771-5.
12. Beatty JD, Atwood M, Tickman R etal. Metaplastic breast cancer: Clinical significance. Am J Surg 2006; 191: 657-64.
13. Gibson GR, Lai L. Metaplastic breast cancer: Clinical traits and outcomes. J Clin Oncol 2004; 22: 844.
14. Barnes PJ, Boutilier R, Chiasson D etal. Metaplastic breast carcinoma: Clinical-pathologic characteristics and HER2/neu expression. Breast Cancer Res Treat 2005; 91: 173-8.
15. Pezzi MC, Lina P-P, Karin C etal. Characteristics and treatment of metaplastic breast cancer: Analysis of 892 cases from the National Cancer Data Base. Ann Surg Oncol 2007; 14: 166-73.
16. Kuo SH, Chen CL, Huang CS etal. Metaplastic carcinoma of the breast: Analysis of eight Asian patients with special emphasis on two unusual cases presenting with inflammatory-type of breast cancer. Anticancer Res 2000; 20: 2219-22.
17. Catroppo JF, Lara JF. Metastatic metaplastic carcinoma of the breast(MCB): An uncharacteristic pattern of presentation with clinicopathologic correlation. Diagn Cytopathol 2001; 25: 285-91.
18. Ng SP, Sheu CY, Shih SL etal. Small metaplastic carcinoma of the breast: A case report. J Med Ultrsound 2003; 11: 118-21.
19. Greenberg D, McIntyre H, Bierre T. Metaplastic breast cancer. Aust Radiol 2004; 48: 243-7.
20. Esses KM, Hagmaier RM, Blanchard SA etal. Carcinosarcoma of the breast: Two case reports and review of the literature. Cases J 2009; 2: 15.
21. Olopade OI, Grushko TA, Huoz D. Advances in breast cancer: Pathways to personalized medicine. Clin Cancer Res 2008; 14: 7988-99.
22. Rakha EA, Reis-Filho JS, Ellis IO. Basal-like breast cancer: A critical review. J Clin Oncol 2008; 26: 2568-81.
23. Choo JR, Nielsen TO. Biomarkers for basal-like breast cancer. Cancers 2010; 2: 1040-65.
24. Fulford LG, Reis-Filho JS, Ryder K etal. Basal-like grade III invasive ductal carcinoma of the breast: Patterns of metastasis and long-term survival. Breast Cancer Res 2007; 9: R4 (doi:10.1186/bcr1636).
25. Drew PJ, Turnbull LW, Chatterjee S etal. Prospective comparison of standard triple assessment and dynamic magnetic resonance imaging of the breast for the evaluation of symptomatic breast lesions. Ann Surg 1999; 230: 680-5.
26. The Breast International Group (BIG) 1-98 Collaborative Group. A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. N Engl J Med 2005; 353: 2747-57.
27. Schneider BP, Winer EP, Foulkes WD etal. Triple-negative breast cancer: Risk factors to potential targets. Clin Cancer Res 2008; 14: 8010-8.